Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Aidigong Maternal & Child Health ( (HK:0286) ).
Aidigong Maternal & Child Health Limited has announced the current composition of its board of directors, confirming Huang Wenhua as chairman and chief executive officer alongside executive directors Li Runping and Meng Lijia, with Wang Bin and Ma Siu Kit serving as independent non-executive directors. The company also detailed the membership of its key governance committees, appointing Ma Siu Kit as chairman of the audit committee and member of the nomination and remuneration committees, and designating Wang Bin as chairman of both the nomination and remuneration committees, a structure that underscores the role of independent directors in oversight and may help strengthen corporate governance, transparency, and investor confidence.
More about Aidigong Maternal & Child Health
Aidigong Maternal & Child Health Limited is a Bermuda-incorporated company listed on the Hong Kong Stock Exchange (stock code: 286). The group focuses on maternal and child health services, operating in the broader healthcare and family wellness sector with a market orientation toward postpartum and related care for mothers and infants.
Technical Sentiment Signal: Sell
Current Market Cap: HK$251.6M
For an in-depth examination of 0286 stock, go to TipRanks’ Overview page.

